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Abstract 
 
Background In the UK, general practitioners/family physicians receive pay for performance 
on management of long-term conditions, according to best-practice indicators.  
Method Management of long-term conditions was compared between 721 adults with 
intellectual disabilities and the general population (n=764,672).  Prevalence of long term 
conditions was determined, and associated factors investigated via logistic regression 
analyses.  
Results Adults with intellectual disabilities received significantly poorer management of all 
long–term conditions on 38/57 (66.7%) indicators. Achievement was high (75.1-100%) for 
only 19.6% of adults with intellectual disabilities, compared with 76.8% of the general 
population. Adults with intellectual disabilities had higher rates of epilepsy, psychosis, 
hypothyroidism, asthma, diabetes, and heart failure. There were no clear associations with 
neighbourhood deprivation. 
Conclusions Adults with intellectual disabilities receive poorer care, despite conditions 
being more prevalent. The imperative now is to find practical, implementable means of 
supporting the challenges that general practices face in delivering equitable care.  
 
Keywords intellectual disabilities, long-term conditions, chronic disease management, 
health, primary health care, general practice 
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Background 
 
People with intellectual disabilities experience poor health and multi-morbidity (NHS 
Scotland, 2004, Oullete-Kuntz, 2004, Oesburg et al, 2011, Cooper et al, 2015). They also 
experience premature death, some of which may be preventable (Heslop et al, 2013; Lauer 
and McCallion, 2015). Despite this, there are significant evidence gaps related to their 
health and health care (Robertson et al, 2015). 
 
People with intellectual disabilities face barriers in accessing health services, compounded 
by communication difficulties, and organisational and social support limitations (Oullete-
Kuntz, 2004). In order to reduce inequities, primary health care providers need to effectively 
manage long-term conditions in keeping with best practice. However, current evidence 
suggests this may not always occur. A Scottish survey of 369 general practitioners (58% 
response rate) revealed, that whilst they recognised the importance of their role in the 
health care of people with intellectual disabilities, they also identified they had a lack of 
experience and training in this area, and limited background information on individual 
patients and knowledge of referral routes and inter-agency communication (Williamson, 
2004). Similar findings were reported in a survey of 912 general practitioners in Australia 
(Lennox et al, 2000), who identified a need to improve health care for people with 
intellectual disabilities, and recognised deficiencies in care provision. Moreover, in a small 
qualitative study with 10 general practitioners in Norway, concerns were highlighted over a 
lack of expertise and support in treating patients with intellectual disabilities (Fredheim, 
2013). Hence, limitations in general practitioners' knowledge and confidence, and the 
challenges of inter-agency communication, rather than general practitioners' values or 
attitudes, may contribute to healthcare access difficulties for adults with intellectual 
disabilities. A survey of 201 practice nurses (nurses who work in primary health care) and 
another of 107 practice nurses also reported a knowledge gap in the care of adults with 
intellectual disabilities, and communication barriers (Melville et al, 2005; Powrie, 2003). 
Additionally, some adults with intellectual disabilities can be reliant on carers to support 
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them in accessing and implementing health care when needed, hence communication within 
the support team or teams is important as well as with the individual (Oullete-Kuntz, 2004). 
 
Service delivery and organisation of primary health care differs between countries. In the UK, 
the contract between general practitioners and the government health departments includes 
pay for performance on specific indicators of management of long term conditions which 
are considered to be evidence-based best-practice (the “Quality and Outcomes Framework”). 
All general practices receiving these payments (95% of practices in Scotland during 
2013/14) have to report their number of patients with the long term conditions specified in 
the Quality and Outcomes Framework annually, and the proportion of these patients whose 
care meets the defined quality indicators. The Quality and Outcomes Framework includes 
the concept of ‘exception reporting’, which allows some patients to be omitted from 
achievement rates, in situations where patients cannot be treated as per the Quality and 
Outcomes Framework guidelines, so that practices are not financially penalised. This may 
include, for example, where patients do not attend for review, or where patients have a 
supervening condition which makes treatment of their condition inappropriate e.g. 
cholesterol reduction where the patient has liver disease. However, data on reasons for 
exception reporting are not collected. Statistics on performance for the whole population 
are collected annually and published (Scottish Government, 2014; 
www.isdscotland.org/qof).  
 
Little is known on the quality of primary health care people with intellectual disabilities 
receive for long-term conditions, as evidence is only available for management of a few 
health conditions, such as diabetes (Taggart, 2013), or clinical processes, such as recording 
blood pressure (Robertson et al, 2015). Taggart (2013) found diabetic control was poor 
amongst 186 people with intellectual disabilities identified through community learning 
disabilities teams or supported living facilities; only 59% had had their HbA1c checked, 15% 
were hypertensive, and 22% had no record of their lipid levels. An Australian health check 
trial with 435 adults with intellectual disabilities found a low frequency at baseline of testing 
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cholesterol levels (5.7%), thyroid function (17.9%), vision (4.6%) and hearing (4.6%) (Lennox 
et al, 2007). An English study reviewed case records of 651 adults registered at 27 
practices, and found that items incentivised in the Quality and Outcomes Framework were 
more likely to have been completed than other items (but were still poorer than reported for 
the general population); recording of blood pressure (87%), body mass index (79%), urine 
testing (37%), hearing assessment (15%) (Chauhan et al, 2010). These studies did not draw 
comparisons with the general population. One large American study was identified that 
investigated management of diabetes among people with developmental disabilities and 
made comparisons with the general population, but the number of people with intellectual 
disabilities included in the sample was not reported (Shireman et al, 2009). We have not 
identified other studies reporting the management of long-term conditions in this 
population. What is clearer is that lower rates of cervical screening and mammography are 
reported for women with intellectual disabilities compared with the general population (Kerr 
et al, 1996; Wood, 2007; Reynolds, 2008; Osbon, 2012; Cobigo et al, 2013), although 
mammography screening was found to be comparable to levels in the general population in 
one study (Biswas, 2005).  
 
While several studies have documented that rates of some conditions are more common in 
people with intellectual disabilities than people without, most have not made direct 
comparisons. Three studies utilised large primary care databases to compare rates of long-
term conditions (Cooper et al, 2015; Carey et al 2016; NHS digital, 2016). Cooper et al 
(2015) found that epilepsy, psychosis, thyroid disorder, dementia, diabetes, asthma and 
stroke/transient ischaemic attacks were more prevalent in the adults with intellectual 
disabilities than the general population. Carey et al (2016) reported a higher prevalence of 
epilepsy, psychosis, hypothyroidism, dementia, and heart failure in the adults with 
intellectual disabilities compared to the general population. Public Health England (NHS 
digital, 2016) reported that epilepsy, psychosis, dementia, hypothyroidism, heart failure, 
diabetes, stroke, asthma and depression were more common in the people with intellectual 
disabilities, whereas cancer, chronic obstructive pulmonary disease, hypertension and 
coronary heart disease were less common. Psychosis (Cooper et al, 2007), dementia 
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(Strydom et al, 2009), and epilepsy (Morgan et al, 2003) have been reported to be higher in 
adults with intellectual disabilities when compared with previously reported (rather than on 
direct comparison) general population rates. Gale et al (2009) reported that asthma occurred 
at a higher rate in people with intellectual disabilities than in the general population, but did 
not make statistical comparisons. Van Schrojenstein Lantman-de Valk et al (2000) compared 
the number of health problems of 318 people with intellectual disabilities with the general 
population registered at the same general practices, and found 2.5 times more in the people 
with intellectual disabilities. They grouped disorders together and found that neurological, 
psychological, ear, eye, general and unspecified, endocrine, and musculoskeletal problems 
were more common in the people with intellectual disabilities. Emerson et al (2016) 
compared physical health outcomes of 299 people with primarily mild intellectual 
disabilities, aged 16-49 years, with 22,927 people without intellectual, and found arthritis, 
cancer, diabetes were more common in the people with intellectual disabilities. Other 
studies have focussed exclusively on older people, rather than all adults with intellectual 
disabilities (e.g. Kappel et al, 1998; Jansen et al, 2013).  
 
Given that people with intellectual disabilities experience high rates of long term conditions, 
access to high quality primary health care services is vital (Lunsky et al, 2013).  Rates of 
hospitalisation for ‘ambulatory care-sensitive conditions’, have been used as an indicator of 
access to, and quality of primary care (Balogh et al, 2010; 2014).  Ambulatory care-sensitive 
conditions are defined as conditions which, if managed effectively at the primary care level, 
should not lead to a hospital admission (Billings et al 1993), for example, epilepsy and 
diabetes. Some research has found people with intellectual disabilities are admitted to 
hospital more frequently than the general population for ambulatory care-sensitive 
conditions (Dunn et al, 2017). However, the extent of differences in the management of long 
term conditions for people with intellectual disabilities compared to the general population 
has not yet been quantified within primary care settings. 
 
The aim of this study was to measure the management of long-term conditions within 
primary health care for adults with intellectual disabilities, and to compare this with the 
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general population, using indicators of best-practice from the Quality and Outcome 
Framework. Secondary aims were to investigate the extent of recognised disease prevalence 
in adults with intellectual disabilities compared with the general population, and the 
influence of neighbourhood deprivation, ability level, accommodation type, age and gender 
upon these. 
  
Materials and Methods 
    
Ethical Approval and Consent 
Ethical approval was obtained from the Multicentre Research Ethics Committee – Scotland A. 
Each individual with intellectual disabilities was invited to consent to participate. Where 
participants lacked decision-making capacity to consent, consent was sought from their 
welfare guardian/attorney or nearest relative, in keeping with Scottish law.  
 
Participants and Setting  
Identification of all adults with intellectual disabilities living within the geographical area of 
Greater Glasgow and Clyde Health Board, Scotland, during 2007-2010 was determined via 
the primary health care register of people with intellectual disabilities. This is updated 
annually with the 631 general practitioners in this area. The general practitioners are 
financially incentivised to maintain and update the register. Within a geographic sub-section 
of the Health Board, adults with intellectual disabilities consented for extraction of their 
health data from their primary health care records.  For comparison, 2006/7 Quality and 
Outcome Framework data for all adult patients within Greater Glasgow and Clyde health 
board (n=764,672) were used. 
 
Process and measures 
The general practitioners allowed access to the electronic and paper health records of their 
consented patients. Data was manually extracted, using a structured data extraction 
template. This included identification of whether they had each of the15 Quality and 
Outcome Framework qualifying conditions (e.g. diabetes, epilepsy, asthma, hypertension), 
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and completion of the 57 Quality and Outcome Framework indicators, including the extent 
of exception reporting, for these conditions when they were identified, and for health 
promoting activities. Age, gender, type of accommodation, level of intellectual disabilities 
(measured by the Vineland Scale), and extent of neighbourhood deprivation based on post-
code using the Scottish Index of Multiple Deprivation (SIMD) (Scottish Government, 2012) 
were also recorded.  
 
Analyses 
Data were entered into a database. The Statistical Package SAS v 9.2 was used to analyse the 
data. Summaries of the characteristics of the adults with intellectual disabilities are provided 
using numbers and percentages. Frequency data were derived to determine point prevalence 
rates of conditions. The prevalence of each condition was examined in the adults with 
intellectual disabilities group, using Poisson models, accounting for the general population 
prevalence as an offset. Within the adults with intellectual disabilities group, we examined 
logistic regression models, allowing for a random practice effect, to determine whether 
there were any associations between the common demographics variables (age, gender, 
deprivation, ability level and accommodation type) and each long term condition. Percentage 
of completion of each indicator within the conditions was derived, and compared with the 
general population via logistic regression models to obtain odds ratios with 95% confidence 
incidence (CI), allowing for practice level to be entered as a random effect.  Similar analysis 
was then performed on each indicator to determine whether any differences existed in the 
patients that were exception reported. 
  
Results 
 
Characteristics of Participants 
Consent was gained for 727 of 836 (87.0%) invited adults. Four were in practices that were 
not participating in the Quality and Outcome Framework, so were excluded from analyses. 
Two were under 18 years old, so were also excluded from analyses (as the Quality and 
Outcome Framework applied to over 18 year olds). Table 1 outlines the study cohort 
 9 
 
characteristics of the remaining 721. As expected, there were more men than women - 398 
(55.2%) men and 323 (44.8%) women; 255 (35.4%) had mild intellectual disabilities, 194 
(26.9%) had moderate, 128 (17.8%) had severe and 143 (19.9%) had profound intellectual 
disabilities. Their mean age was 44.3 years (range of 18-92).  
 
- insert table 1 about here -  
 
Prevalence of identified long-term conditions 
Table 2 shows the prevalence of long-term Quality and Outcome Framework qualifying 
conditions for both population groups. Adults with intellectual disabilities were significantly 
more likely than adults in the general population to have epilepsy (28.2% versus 0.8%, 
p<0.0001), psychosis (7.6% versus 0.9%, p<0.0001), asthma (9.2% versus 5.3%; p<0.0001), 
diabetes (6.4% versus 3.4%; p<0.0001), heart failure (2.5% versus 0.9%, p<0.001), and 
hypothyroidism (5.3% versus 2.8%, p=0.0001). No significant difference was found between 
the two populations in the rates of chronic obstructive pulmonary disease, coronary heart 
disease, chronic kidney disease or stroke. The number of people with dementia, requiring 
palliative care, atrial fibrillation or cancer was too small in the intellectual disabilities group 
to make any comparisons with confidence. Whilst hypertension was common amongst the 
people with intellectual disabilities (12.8%), it occurred at a similar rate as in the general 
population. 
 
- insert table 2 about here – 
 
Factors associated with long-term conditions within the intellectual disabilities population 
Within the adults with intellectual disabilities, analyses examined whether specific 
demographics (age group, sex, neighbourhood deprivation, ability and accommodation 
type) were associated with having each individual long-term condition (tables not included). 
Generally, results indicated few associations between the patient demographics and each 
long-term condition. Exceptions were: 
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 asthma, which had reduced odds at lower ability (p-value = 0.0317 for ability, odds ratio 
[OR] for moderate 0.49, 95% CI 0.25-0.95, OR for severe 0.41 95% CI 0.18-0.95 , OR for 
profound 0.40 95% CI 0.18-0.89);  
 diabetes, which had greater odds at older age (p-value = 0.0032 for age, OR for age 
group 45-54, 7.80, CI 1.63-37.26, OR for age group 55+ 13.69, CI 2.83-66.21), and for 
adults living in more deprived neighbourhoods (p-value = 0.0227 for deprivation, OR for 
most deprived 3.40, CI 1.28-9.01 and OR for intermediate deprived areas 3.39, CI 1.35-
8.51); 
 epilepsy, which had increased odds at lower ability (p-value < 0.0001 for ability, OR for 
profound 4.36, CI 2.56-7.41), and for adults living with paid carer support (p-value = 
0.0142 for accommodation OR 1.95, CI 1.21-3.15);  
 hypertension, which had increased odds at older age (p-value < 0.0001 for age, OR for 
45-54 5.89, CI 1.89-18.30 and OR for 55+ 11.31, CI 3.66-34.94), and decreased odds at 
lower ability (p-value = 0.0021 for ability, OR for profound 0.13, CI 0.04-0.39);  
 hypothyroidism, which had increased odds for women (p-value – 0.0410 for gender, OR 
2.13, CI 1.03-4.41); 
 case-screening for depression, which had greater odds for adults with paid carer support 
or living independently compared with those living with family (p-value = 0.0001 for 
accommodation, OR for paid carer 2.48, CI 1.42-4.32, OR for living independently 4.17 
CI 2.14-8.15), and lower odds for adults with profound levels of intellectual disabilities 
(p-value = 0.0468 for ability, OR for profound 0.39, CI 0.20-0.76).  
 
Management of long-term conditions 
Table 3 compares achievement/completion frequency of the indicators for each condition 
and for health promoting activities prescribed in the quality and outcome framework. 
Adjusted for random practice effects, significant differences were found across the 
indicators where conditions were present in large enough numbers to test in the intellectual 
disabilities group, including management of epilepsy, diabetes, hypertension, chronic 
obstructive pulmonary disease, asthma, hypothyroidism, and heart failure (table 3). In 
addition to the poorer achievement on management of long-term conditions, health 
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promoting activities including cervical screening, recording smoking-status, and offering 
smoking cessation advice were less likely to be addressed for the adults with intellectual 
disabilities.  
 
Percentages of achievement were lower across all indicators apart from four, significantly so 
for 38/57 (66.7%). Data on dementia, palliative care, and cancer were not collected due to 
the nature of the indicators and the expectation of very small numbers in the intellectual 
disabilities group. 
 
Table 4 shows that the level of achievement was less than, or equal to, 50% for 46.4% of 
indicators for the adults with intellectual disabilities, compared with 1.8% for the general 
population. The achievement on indicators was high (between 75.1-100%) for the majority 
(76.8%) of adults in the general population, but low (19.6%) for the adults with intellectual 
disabilities.  
 
- insert tables 3 and 4 about here – 
 
Table 5 shows that the proportions of ‘exception reporting’ for indicators of each condition 
and health promoting activities were higher/more common for people with intellectual 
disabilities across 29/56 (51.8%) of indicators, being statistically significant for 8/56 (14.3%) 
of these indicators, across conditions of diabetes, hypothyroidism, psychosis and 
depression.  Exception reporting was reported to be significantly lower/less common for 
people with intellectual disabilities for all epilepsy indicators. We were unable to report 
statistical differences for 18/56 (32.1%) indicators due to the low occurrence of some 
conditions. In general, these findings were mixed, but the very high rates of exception 
reporting for case-finding for depression in people with diabetes or coronary heart disease, 
and for offering smoking cessation advice to smokers is notable. 
  
-insert table 5 about here- 
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Discussion 
 
Principal findings and interpretation 
Long-term conditions were more poorly managed for people with intellectual disabilities 
than for the general population, across the full range of conditions studied. The indicators 
of quality of management that were used are evidence-based; these are the pathways to 
improving health. Adults with intellectual disabilities are experiencing an inequity in health 
care. This finding has previously been reported for diabetes care; our study is novel for 
measuring the extent of inequality across a wide range of long-term conditions and health-
promoting actions. 
 
The exceptions to this trend across all the indicators was that the adults with intellectual 
disabilities who had diabetes and chronic kidney disease were more likely to have a blood 
pressure below the target if they had had their blood pressure taken (but were less likely to 
have had their blood pressure taken). Adults with Down syndrome are known to have lower 
blood pressure than the general population (Morrison et al, 1996); 3/46 (6.5%) people with 
diabetes and 2/15 (13.3%) with chronic kidney disease had Down syndrome. 
 
Long-term conditions are more common for adults with intellectual disabilities compared to 
the general population.  We found that adults with intellectual disabilities have higher rates 
of epilepsy, psychosis, asthma, diabetes, hypothyroidism and heart failure. No consistent 
effect of neighbourhood deprivation, ability level, nor accommodation type was found with 
prevalence of individual long-term conditions. Age and gender associations for diabetes, 
hypertension, and hypothyroidism were as expected from the general population literature, 
and the ability-related finding for epilepsy is well reported amongst people with intellectual 
disabilities. The associated level of ability finding with asthma is novel, but given the 
number of analyses undertaken, may be merely a chance finding. No cause-effect 
relationship can be inferred from the association of epilepsy, nor case screening for 
depression, with living with paid carer support. 
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Comparison with existing literature 
There is limited research reporting management of long-term conditions, so our findings are 
novel, and we have added stronger support to previous findings of poor management of 
specifically diabetes (Taggart et al, 2013), and on health promoting activities (Kerr et al, 
1996; Wood, 2007; Reynolds, 2008; Osbon, 2012), through a larger sample size, 
population-based approach, and drawing direct comparisons with the general population. 
 
The odds ratios we found for epilepsy, psychosis, asthma, diabetes, and hypothyroidism 
were strikingly similar to those reported from another primary care database in a different 
part of Scotland, thus providing greater confidence in these results (Cooper at al, 2015). The 
exceptions were for heart failure (occurring in only 18 individual in this current study), 
which was no more common in people with intellectual disabilities, and stroke/transient 
ischaemic attack (occurring in only 13 individual in this current study), which was marginally 
more common in the group with intellectual disabilities (Cooper et al, 2015). Recent findings 
from a primary care database in England reported similar trends to these results, with a 
higher prevalence of epilepsy, psychosis, hypothyroidism and heart failure (Carey et al, 
2016). The exception to this was dementia, which was not found to be more prevalent in the 
current study.  It is well reported that epilepsy (Morgan et al, 2003) and psychosis (Cooper 
et al, 2007) are more prevalent in adults with intellectual disabilities than the general 
population. The prevalence of epilepsy for adults with intellectual disabilities in the current 
study (28.4%) is at the mid-range of that quoted (14-44%) in a systematic review of 
prevalence studies (Bowley & Kerr, 2000). In a large, population-based study of 1,097 adults 
with intellectual disabilities in England, primary care data revealed that 12% had asthma 
(Gale et al, 2009), similar to our finding of 9.3%, both notably higher than in the general 
population. The replication of this finding provides greater credibility to it, although the 
lower end of our confidence interval was only 1.39. Possible explanations are the higher 
rates of obesity in adults with intellectual disabilities, or misdiagnosis of reflux pneumonitis 
or aspiration pneumonia.  The prevalence of the other long-term conditions has been 
studied to a lesser extent and not always in comparison with the general population; more is 
known about older adults with intellectual disabilities than the whole adult population, and 
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for adults with cognitive limitations from a range of conditions, rather than specifically 
intellectual disabilities (Richard and Slolze, 2011).  
 
Exception reporting was higher across certain indicators for the conditions of diabetes, 
hypothyroidism, psychosis and depression.  However, exception reporting was significantly 
lower for people with intellectual disabilities for epilepsy on all indicators. Thus, the findings 
are mixed, and as data is not collected on the reasons for ‘exception reporting’, the 
conclusions that can be made are limited. The small number of people with some of the 
conditions also limits the conclusions that can be drawn. However, it is highly notable that 
45.3% of the smokers were exceptions from being offered smoking cessation advice 
compared with only 1.3% of the general population; and 33.3% of the people with diabetes 
or coronary heart disease were exceptions for case-finding for depression compared with 7% 
of the general diabetic population. Little attention has been given to ‘exception reporting’ in 
previous research, although, some general population studies have found exception 
reporting  to be higher for more complex conditions (Doran et al, 2008b; Dixon et al, 2011). 
A UK study reported an overall rate of 6.2% for exception coding of patients with intellectual 
disabilities (Chauhan et al (2010), which is similar to exception reporting nationally (6%) 
(Doran et al. 2006). However, the authors noted that it is possible that some long term 
conditions are not being either recognised or being coded appropriately among people with 
intellectual disabilities, and the extent to which this occurs remains unknown. Exception 
reporting for people with intellectual disabilities should be investigated further in future 
research, to identify if there should be a specific training agenda for primary care on the 
management of conditions for people with intellectual disabilities. 
 
Independent association of neighbourhood deprivation with long-term conditions 
Extent of neighbourhood deprivation was not found to be a predictor of long-term 
conditions for people with intellectual disabilities in this study, except for diabetes. This 
differs from findings in the general population, and may reflect the complexity of the lives 
of adults with intellectual disabilities. Both children and adults with intellectual disabilities 
are known to be more likely to live in more deprived areas (Morgan et al, 2000; Emerson et 
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al, 2006; Cooper et al, 2011) but neighbourhood deprivation has not been associated with 
ill-health, perhaps due to complexities of size and location of housing stock for supported 
tenancies, and influences of family of origin as well as paid carers (Cooper, 2011). Area 
deprivation has also been reported to not influence access to social supports, daytime 
primary health-care services or hospital admissions among people with intellectual 
disabilities (Cooper et al, 2011). For people with intellectual disabilities, there appear to be 
more important factors that influence their health and health care, such as the impact of 
their disabilities and the actions and influences of their paid or family carers. Thus, factors 
that influence health inequalities in the general population cannot be assumed to be the 
same for people with intellectual disabilities, and health efforts only focused on the most 
deprived communities would only benefit some people with intellectual disabilities and not 
others with similar health needs (Cooper et al, 2011). 
 
Strengths and limitations  
This was a large population-based cohort of adults with intellectual disabilities for whom 
detailed information was collected from their primary health care records. Comparisons 
were made with the Scottish general population on identical indicators. We have no reason 
to suspect these results are not generalizable to other affluent countries with well-developed 
primary health care services.  
 
Limitations include the use of routinely collected clinical data. Additionally, adults with 
intellectual disabilities are included in the comparison data as it reports whole population 
data – however, only 0.5% of the whole population in this data have intellectual disabilities, 
so the impact is small and given the direction of findings, the main research results would 
have been more pronounced had it been possible to remove them (which was not possible).  
Moreover, we were not able to adjust for gender and age when making comparisons, as this 
was not known for the general population. We recognise that the people with intellectual 
disabilities may be younger and more male than the comparison general population. 
Furthermore, data extraction was manual for adults with intellectual disabilities, and 
electronic for the general population.  Long-term conditions may conceivably be under-
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represented in both the intellectual disabilities and general population groups, as the study 
design relied on those conditions already recorded in primary health care records.  
 
A further limitation is that the long-term conditions included in the Quality and Outcome 
Framework may not include all those most relevant to people with intellectual disabilities, 
such as gastro-intestinal reflux disease, constipation, dysphagia, repeated chest infection 
and aspiration, sensory or physical impairments, osteoporosis, repeated injuries/accidents 
and falls, and oral health. However, focussing on the Quality and Outcomes Framework data 
did allow for an established evidence-based approach to measuring the quality of primary 
health care management, and comparison with the general population.  
 
Clinical Implications 
General practitioners and practice nurses chose their vocational occupations, and the survey 
data described in the introduction supports the view that they wish to provide the best care 
for all of their patients, including adults with intellectual disabilities. Our study suggests 
that this is not yet happening, and we need a better understanding of why this is and how to 
address it.  
 
The failings in the management of long-term conditions highlights the need for staff 
training in primary care, and adds support for the introduction of specific interventions such 
as health checks in primary care for people with intellectual disabilities. Health checks have 
been found to be clinically and cost effective (Cooper et al, 2014), but unlike England and 
Wales, where practices are paid to conduct health checks, they have not been introduced in 
Scotland where this study took place.  
 
Future research is needed to identify trends in the quality of long term condition 
management in primary care, any geographical variation in care for this population and its 
determinants, and to determine whether the current health care inequality gap is closing or 
widening. 
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Table 1. Characteristics of participants 
 
Baseline Characteristics  Number of participants  
(N=721)  
N (%) 
Gender 
Female 
 
323 (44.8%) 
Male 398 (55.2%) 
Age (years) 
18-34 
 
192 (26.6%) 
35-44 172 (23.9%) 
45-54 174 (24.1%) 
55+ 183 (25.4%) 
Level of intellectual disabilities 
Mild 
 
255 (35.4%) 
Moderate 194 (26.9%) 
Severe 128 (17.8%) 
Profound 143 (19.9%) 
Down Syndrome 98 (13.6%) 
Neighbourhood deprivation level* 
1 (least deprived: SIMD deciles 1-7) 
 
268 (38.2%) 
2 (SIMD deciles 8-9) 245 (34.9%) 
3 (most deprived: SIMD decile 10)  189 (26.9%) 
* 19 patients did not have information available to determine neighbourhood deprivation. 
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Table 2. Prevalence of long-term conditions in adults with intellectual disabilities compared with the general population  
Types of long-term condition conditions 
 
Intellectual disabilities 
(N=721) 
N (%) 
General Population 
(N=764,672) 
N (%) 
Rate Ratio (95% CI) P value 
Epilepsy 203 (28.2%) 6,268 (0.8%) 34.35 (29.93-39.41) <0.0001 
Psychosis  55 (7.6%) 6,899 (0.9%) 8.46 (6.49-11.01) <0.0001 
Asthma 66 (9.2%) 40,427 (5.3%) 1.73 (1.36-2.20) <0.0001 
Diabetes 46 (6.4%) 25,944 (3.4%) 1.88 (1.41-2.51) <0.0001 
Heart Failure 18 (2.5%) 7,153 (0.9%) 2.67 (1.68-4.24) <0.0001 
Hypothyroidism 38 (5.3%) 21,559 (2.8%) 1.87 (1.36-2.57) 0.0001 
Chronic Obstructive Pulmonary Disease 9 (1.2%) 16,858 (2.2%) 0.57 (0.29-1.09) 0.0879 
Coronary Heart Disease 25 (3.5%) 34,711(4.5%) 0.76 (0.52-1.13) 0.1780 
Chronic Kidney Disease 15 (2.1%) 12,003 (1.6%) 1.33 (0.80-2.20) 0.2753 
Dementia 2 (0.3%) 4,205 (0.5%) 0.50 (0.13-2.02) 0.3332 
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Atrial fibrillation  7 (1.0%) 9,953 (1.3%) 0.75 (0.36-1.56) 0.4380 
Palliative Care 1 (0.1%) 672 (0.1%) 1.58 (0.22-11.20) 0.6482 
Cancer (in the last four years) 7 (1.0%) 6,528 (0.9%) 1.14 (0.54-2.39) 0.7336 
Stroke 13 (1.8) 15,008 (2.0%) 0.92 (0.53-1.58) 0.7597 
Hypertension 92 (12.8%) 94,322 (12.3%) 1.03 (0.84-1.27) 0.7452 
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Table 3. Primary care management of long-term conditions for adults with intellectual disabilities compared with general population  
Individual Indicators Adults with ID 
Indicators met/eligible adults 
(%) 
General Population 
Indicators met/eligible adults 
(%) 
Odds Ratio (95% 
CI) 
P value 
Epilepsy N=203     N=6,268 
% of patients on drug treatment for epilepsy who have a record of 
seizure frequency in the previous 15 months 
163/203 (80.3%) 5,561/6,254 (88.9%) 0.51 (0.35-0.75) 0.0008 
% of patients on drug treatment for epilepsy who have a record of 
medication reviews  in the previous 15 months 
166/203 (81.8%) 5,511/6,253 (88.1%) 0.60 (0.40-0.88) 0.0107 
% of patients on drug treatment for epilepsy who are seizure free 
for 12 months  in the previous 15 months 
62/203 (30.5%) 3,179/6,197 (51.3%) 0.42 (0.31-0.58) 0.0046 
Diabetes N=46                                                 N=25,944 
% of patients with a  record of micro-albuminuria test  in the 
previous 15 months 
15/46 (32.6%) 19,717/24,213 (81.4%) 0.11 (0.05-0.21) <0.0001 
% of patients with a record of total cholesterol  in the previous 15 
months 
28/46 (60.9%) 24,404/26,153 (93.3%) 0.12 (0.06-0.23) <0.0001 
% of patients whose last total cholesterol is 5mmol/l or less 22/46 (47.8%) 19,876/26,153 (76.0%) 0.29 (0.16-0.53) 0.0002 
% of patients with a record of neuropathy testing  in the previous 
15 months 
13/46 (28.3%) 21,631/26,153 (82.7%) 0.08 (0.04-0.15) <0.0001 
% of patients with a record of HbA1c or equivalent  in the 
previous 15 months 
33/46 (71.7%) 24,690/26,153 (94.4%) 0.16 (0.08-0.32) <0.0001 
% of patients in whom last HbA1c test is 10 or less 29/46 (63.0%) 22,393/26,153 (85.6%) 0.30 (0.16-0.56) 0.0005 
% of patients in whom last HbA1c test is 7.5 or less 20/46 (43.5%) 15,006/26,153 (57.4%) 0.58 (0.32-1.07) 0.0814 
% of patients with record of retinal screening  in the previous 15 
months 
32/46 (69.6%) 23,415/26,153 (89.5%) 0.26 (0.13-0.51) 0.0003 
% of patients with a recording of BMI  in the previous 15 months 37/46 (80.4%) 24,393/26,153 (93.3%) 0.32 (0.15-0.70) 0.0056 
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% of patients who had influenza immunisation in the preceding 1 
September – 31 march 
29/46 (63.0%) 19,667/26,153 (75.2%) 0.57 (0.30-1.07) 0.0791 
% of patients with a record of presence or absence of peripheral 
pulses  in the previous 15 months 
27/46 (58.7%) 21,845/26,153 (83.5%) 0.29 (0.15-0.56) 0.0005 
% of patients with record of kidney screen (EGRF or serum 
creatinine) in the previous 15 months   
31/46 (67.4%) 24,452/26,153 (93.5%) 0.15 (0.08-0.30) <0.0001 
% of patients with a record of blood pressure  in the previous 15 
months 
39/46 (84.8%) 25,247/26,153 (96.5%) 0.22 (0.09-0.52) 0.0011 
% of patients with diabetes whose last blood pressure is 145/85 
or less 
35/46 (76.1%) 19,868/26,153 (76.0%) 1.03 (0.50-2.11) 0.9416 
Hypertension N=92                                                 N=94,322 
% of patients with a record of blood pressure in the previous 9 
months   
68/92 (73.9%) 85,522/94,848 (90.2%) 0.29 (0.18-0.47) <0.0001 
% of patients with a  blood pressure of 150/90 or less in the 
previous 9 months 
64/92 (69.6%) 71,660/94,848 (75.6%) 0.73 (0.46-1.16) 0.1776 
Asthma N=66                                                 N=40,427 
% of patients who have had an asthma review  in the previous 15 
months 
21/66 (31.8%) 28,953/40,412 (71.6%) 0.18 (0.10-0.30) <0.0001 
% of patients aged 8+ diagnosed as having asthma with measures 
of variability or reversibility, from 1.4.07 
3/18 (16.7%) 1,231/1,664 (74.0%). 0.04 (0.01-0.22) 0.0009 
Heart Failure N=18                                                 N=7,153 
% of patients confirmed by echocardiogram or specialist, for 
diagnoses after 1.4.06  
4/7 (57.1%) 294/590 (49.8%) - - 
% of patients with heart failure due to left ventricular dysfunction 
treated with ACE inhibitor or angiotensin receptor blocker (unless 
contraindicated) 
5/18 (27.8%) 4,426/5,400 (82.0%) 0.08 (0.03-0.26) 0.0003 
Chronic Obstructive Pulmonary Disease (COPD) N=9                                                    N=16,858 
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% of all patients with  diagnosis confirmed by spirometry 
including reversibility testing 
4/9 (44.4%) 15,175/16,914 (89.7%) 0.08 (0.02-0.43) 
  
0.0091 
% of patients with  a record of FeV1  in the previous 15 months 4/9 (44.4%) 14,239/16,914 (84.2%) 0.13 (0.03-0.67) 0.0216 
% of patients receiving inhaled treatment with a record that 
inhaler technique has been checked 
5/8 (62.5%) 10,489/13,018 (80.6%) 0.30 (0.05-1.87) 0.1580 
% of patients  who have had influenza immunisation in 
preceeding 1 September – 31 March 
8/9 (88.9%) 12,903/16,914 (76.3%) 2.56 (0.21-31.92) 0.4080 
Hypothyroidism N=38                                                  N=21,559 
% of patients with a record of thyroid function tests  in the 
previous 15 months 
30/38 (78.9%) 20,707/21,664 (95.6%) 0.18 (0.08-0.41) 0.0002 
Coronary Heart Disease N=25                                                  N=34,711 
% of patients with a record of total cholesterol  in the previous 15 
months 
13/25 (52.0%) 30,888/34,635 (89.2%) 0.12 (0.05-0.28) <0.0001 
% of patients with a  total cholesterol of 5mmol/l or less  in the 
previous 15 months 
11/25 (44.0%) 25,462/34,635 (73.5%) 0.29 (0.12-0.68) 0.0065 
% of patients with newly diagnosed angina referred for exercise 
testing &/or specialist assessment, after 1.4.03 
5/11 (45.5%) 3,056/3,473 (88.0%) 0.09 (0.02.0.40) 0.0055 
% of patients with a record of influenza immunisation in 
preceeding 1 September – 31 March 
15/24 (62.5%) 27,083/34,635 (78.2%) 0.46 (0.19-1.13) 0.0858 
% of patients with a record of taking aspirin/anti-platelet or anti-
coagulant in the previous 15 months (unless contraindicated)  
18/25 (72.0%) 32,149/34,624 (92.9%) 0.21 (0.08-0.53) 0.0025 
% of patients with a history of MI treated with ACE inhibitor or 
angiotensin II antagonist, if diagnosed after 1.4.03 
1/6 (16.7%) 3,177/3,890 (81.7%) 0.04 (0.002-0.72) 0.0350 
% of patients with a record of blood pressure in the previous 15 
months   
18/25 (72.0%) 32,952/34,635 (95.1%) 0.13 (0.05-0.34) 0.0003 
% of patients with a blood pressure of 150/90 or less in the 
previous 15 months 
18/25 (72.0%) 30,030/34,635 (86.7%) 0.42 (0.16-1.10) 0.0736 
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% of patients currently treated with a beta blocker (unless 
contraindicated) 
10/25 (40.0%) 19,640/34,510 (56.9%) 0.48 (0.20-1.13) 0.0892 
Chronic Kidney Disease N=15                                                  N=12,003 
% of patients treated with ACE inhibitor or angiotensin receptor 
blocker (unless contraindicated) 
6/15 (40.0%) 6,701/9,228 (72.6%) 0.25 (0.08-0.82) 0.0249 
% of patients with a  record of blood pressure  in the previous 15 
months 
13/15 (86.7%) 13,134/13,414 (97.9%) 0.13 (0.02-0.76) 0.0265 
% of patients with a blood pressure of 140/85 or less  in the 
previous 15 months 
11/15 (73.3%) 9,086/13,414 (67.7%) 1.12 (0.31-4.06) 0.8496 
Psychosis N=55                                                  N=6,899 
% of patients with a record of comprehensive care plan agreed 
with individual, family or carer 
18/40 (45.0%) 3,765/5,858 (64.3%) 0.23 (0.11-0.48) 0.0004 
% of patients with a record of review and evidence of 
participation in routine health promotion/prevention advice  in 
the previous 15 months 
0/53 (0.0%) 4,696/5,966 (78.7%) - - 
% of patients on lithium therapy with a record of lithium levels in 
a therapeutic range in the previous 6 months 
4/11 (36.4%) 771/ 987 (78.1%) 0.03 (0.003-0.29) 0.0085 
% of patients on lithium therapy with a record of serum creatinine 
and TSH   in the previous 15 months 
4/11 (36.4%) 879/1,023 (85.9%) - - 
Atrial Fibrillation N=7                                                    N=9,953 
% of patients treated with anti-coagulant or anti-platelet drug 
therapy 
5/7 (71.4%) 9,299/9,934 (93.6%) 0.16 (0.02-1.30) 0.0756 
% of patients from 1.4.07 with diagnosis confirmed by EEG 
specialist  
2/4 (50.0%) 1,250/1,581 (79.1%) 0.12 (0.002-7.16) 0.1986 
Stroke N=13                                                  N=15,008 
% of patients with a record of total cholesterol  in the previous 15 
months 
 6/13 (46.2%) 12,825/15,046 (85.2%) 0.13 (0.04-0.48) 0.0051 
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% of patients with a total cholesterol of 5mmol/l or less in the 
previous 15 months 
4/13 (30.8%) 10,302/15,046 (68.5%) 0.21 (0.06-0.80) 0.0262 
% of patients with a record of blood pressure in the previous 15 
months 
10/13 (76.9%) 14,036/15,046 (93.3%) 0.22 (0.05-1.00) 0.0501 
% of patients with a blood pressure reading of 150/90 or less in 
the previous 15 months 
10/13 (76.9%) 12,535/15,046 (83.3%) 0.65 (0.15-2.83) 0.5289 
% of patients with non-haemorrhagic stroke or history of 
transient ischaemic attacks with record of taking anti-platelet or 
anti-coagulant (unless contraindicated) 
7/13 (53.8%) 8,369/9,130 (91.7%) 0.09 (0.03-0.33) 0.0017 
% of patients with a record of influenza immunisation in the 
preceeding 1 September – 31 March  
6/13 (46.2%) 10,937/15,046 (72.7%) 0.32 (0.09-1.12) 0.0699 
% of new patients with a stroke with a record of referral for 
further investigation 
1/4 (25.0%) 680/1,021 (66.6%) - - 
Depression N=66                                                  N=54,370 
% on diabetes or coronary heart disease register for whom case 
finding for depression has been undertaken 
8/66 (12.1%) 42,101/54,284 (77.6%) 0.04 (0.02-0.08) <0.0001 
Health Promotion       
% of patients with any of the following: coronary heart disease, 
stroke or TIA, hypertension, diabetes, COPD or asthma, who have 
a record of smoking status in the previous 15 months, except 
never-smokers who need the recording once since diagnosis 
162/190 (85.3%) 148,285/155,235 (95.5%) 0.25 (0.17-0.38) <0.0001 
% of patients with record of smoker status with any  of: coronary 
heart disease, stroke or TIA, hypertension, diabetes, COPD or 
asthma, who are offered smoking cessation advice or specialist 
referral  
18/53 (34.0%) 36,762/39,830 (92.3%) 
 
0.04 (0.02-0.07) <0.0001 
% of female patients aged 21-60) whose notes record a cervical 
smear has been performed in the last five years (Standard 40 - 
80%) 
51/221 (23.1%) 144,991/158,765 (91.3%) 0.03 (0.02-0.04) <0.0001 
Due to a slight difference in dates for recording the achievement information and the exception reporting, the denominators for the general population (which 
includes the number of patients who can appropriately be included, plus the number of patients who may be classed as exception reported) may not always agree 
with the number of patients having a condition. 
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Table 4 . Proportion of indicators met for adults with qualifying long term conditions compared with the general population 
 
*Excludes 1 indicator for which exception reporting was not available 
  
 
 
 
 
 
 Indicators  
(n=56*),  
N (%) 
Percentage achievement Adults with intellectual disabilities General Population 
0-25.0% 5 (8.9%) 0 (0) 
25.1-50.0% 21 (37.5%) 1 (1.8) 
50.1-75.0% 19 (33.9%) 12 (21.4%) 
75.1-100% 11 (19.6%) 43 (76.8%) 
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Table 5. Exception reporting of primary care management of long-term conditions for adults with intellectual disabilities compared 
with the general population  
Individual Indicators Adults with ID 
Indicators met/eligible adults 
(%) 
General Population 
Indicators met/eligible adults 
(%) 
Odds Ratio (95% 
CI) 
P value 
Epilepsy N=203     N=6,268 
% of patients on drug treatment for epilepsy who have a record of 
seizure frequency in the previous 15 months 
4/203 (2.0%) 501/6,254 (8.0%) 0.19 (0.07-0.53) 0.0018 
% of patients on drug treatment for epilepsy who have a record of 
medication reviews  in the previous 15 months 
5/203 (2.5%) 521/6,253 (8.3%) 0.23 (0.09-0.58) 0.0022 
% of patients on drug treatment for epilepsy who are seizure free 
for 12 months  in the previous 15 months 
8/203 (3.9%) 1,945/6,197 (31.4%) 0.07 (0.03-0.15) <0.0001 
Diabetes N=46                                                 N=25,944 
% of patients with a  record of micro-albuminuria test  in the 
previous 15 months 
7/46 (15.2%) 1,979/24,213 (8.2%) 1.87 (0.79-4.43) 0.1480 
% of patients with a record of total cholesterol  in the previous 15 
months 
5/46 (10.9%) 942/26,153 (3.6%) 2.89 (1.07-7.79) 0.0370 
% of patients whose last total cholesterol is 5mmol/l or less 6/46 (13.0%) 2,884/26,153 (11.0%) 1.15 (0.46-2.86) 0.7527 
% of patients with a record of neuropathy testing  in the previous 
15 months 
7/46 (15.2%) 2,299/26,153 (8.8%) 1.56 (0.65-3.75) 0.3069 
% of patients with a record of HbA1c or equivalent  in the 
previous 15 months 
2/46 (4.3%) 959/26,153 (3.7%) 1.12 (0.25-4.98) 0.8741 
% of patients in whom last HbA1c test is 10 or less 3/46 (6.5%) 2,000/26,153 (7.6%) 0.78 (0.23-2.66) 0.6782 
% of patients in whom last HbA1c test is 7.5 or less 6/46 (13.0%) 3,946/26,153 (15.1%) - - 
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% of patients with record of retinal screening  in the previous 15 
months 
6/46 (13.0%) 2,721/26,153 (10.4%) 1.26 (0.51-3.13) 0.6096 
% of patients with a recording of BMI  in the previous 15 months 3/46 (6.5%) 1,033/26,153 (3.9%) - - 
% of patients who had influenza immunisation in the preceding 1 
September – 31 march 
6/46 (13.0%) 4,803/26,153 (18.4%) 0.61 (0.24-1.51) 0.2720 
% of patients with a record of presence or absence of peripheral 
pulses  in the previous 15 months 
5/46 (10.9%) 2,233/26,153 (8.5%) 1.06 (0.39-2.88) 0.9054 
% of patients with record of kidney screen (EGRF or serum 
creatinine) in the previous 15 months   
7/46 (15.2%) 904/26,153 (3.5%) 4.93 (2.07-11.74) 0.0007 
% of patients with a record of blood pressure  in the previous 15 
months 
4/46 (8.7%) 582/26,153 (2.2%) 3.94 (1.33-11.74) 0.0153 
% of patients with diabetes whose last blood pressure is 145/85 
or less 
4/46 (8.7%) 2,094/26,153 (8.0%) 1.01 (0.34-2.97) 0.9899 
Hypertension N=92                                                 N=94,322 
% of patients with a record of blood pressure in the previous 9 
months   
3/92 (3.3%) 3,293/94,848 (3.5%) 0.74 (0.23-2.43) 0.6129 
% of patients with a  blood pressure of 150/90 or less in the 
previous 9 months 
3/92 (3.3%) 6,646/94,848 (7.0%) 0.39 (0.12-1.28) 0.1200 
Asthma N=66                                                 N=40,427 
% of patients who have had an asthma review  in the previous 15 
months 
8/66 (12.1%) 5,564/40,412 (13.8%) 0.72 (0.32-1.58) 0.4039 
% of patients aged 8+ diagnosed as having asthma with measures 
of variability or reversibility, from 1.4.07 
10/18 (55.6%) 265/1,664 (15.9%) 9.49 (2.83-31.82) 0.0014 
Heart Failure N=18                                                 N=7,153 
% of patients confirmed by echocardiogram or specialist, for 
diagnoses after 1.4.06  
2/7 (28.6%) 76/590 (12.9%) - - 
% of patients with heart failure due to left ventricular dysfunction 
treated with ACE inhibitor or angiotensin receptor blocker (unless 
3/18 (16.7%) 558/5,400 (10.3%) 1.78 (0.44-7.16) 0.3937 
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contraindicated) 
Chronic Obstructive Pulmonary Disease (COPD) N=9                                                    N=16,858 
% of all patients with  diagnosis confirmed by spirometry 
including reversibility testing 
0/9 (0.0%) 1,733/16,914 (10.2%) - - 
% of patients with  a record of FeV1  in the previous 15 months 1/9 (11.1%) 2,656/16,914 (15.7%) 0.71 (0.06-8.94) 0.7573 
% of patients receiving inhaled treatment with a record that 
inhaler technique has been checked 
1/8 (12.5%) 1,408/13,018 (10.8%) 1.32 (0.09-18.75) 0.8086 
% of patients  who have had influenza immunisation in 
preceeding 1 September – 31 March 
0/9 (0.0%) 3,072/16,914 (18.2%) - - 
Hypothyroidism N=38                                                  N=21,559 
% of patients with a record of thyroid function tests  in the 
previous 15 months 
2/38 (5.3%) 291/21,664 (1.3%) 5.15 (1.07-24.69) 0.0411 
Coronary Heart Disease N=25                                                  N=34,711 
% of patients with a record of total cholesterol  in the previous 15 
months 
0/25 (0.0%) 2,074/34,635 (6.0%) - - 
% of patients with a  total cholesterol of 5mmol/l or less  in the 
previous 15 months 
1/25 (4.0%) 4,282/34,635 (12.4%) 0.30 (0.04-2.56) 0.2545 
% of patients with newly diagnosed angina referred for exercise 
testing &/or specialist assessment, after 1.4.03 
1/11 (9.1%) 248/3,473 (7.1%) 1.07 (0.09.12.83) 0.9541 
% of patients with a record of influenza immunisation in 
preceeding 1 September – 31 March 
1/24 (4.2%) 5,804/34,635 (16.8%) 0.19 (0.02-1.63) 0.1231 
% of patients with a record of taking aspirin/anti-platelet or anti-
coagulant in the previous 15 months (unless contraindicated)  
0/25 (0.0%) 1,187/34,624 (3.4%) - - 
% of patients with a history of MI treated with ACE inhibitor or 
angiotensin II antagonist, if diagnosed after 1.4.03 
2/6 (33.3%) 427/3,890 (11.0%) 4.89 (0.44-54.26) 0.1505 
% of patients with a record of blood pressure in the previous 15 0/25 (0.0%) 993/34,635 (2.9%) - - 
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months   
% of patients with a blood pressure of 150/90 or less in the 
previous 15 months 
0/25 (0.0%) 1,821/34,635 (5.3%) - - 
% of patients currently treated with a beta blocker (unless 
contraindicated) 
4/25 (16.0%) 9,720/34,510 (28.2%) 0.55 (0.17-1.76) 0.2949 
Chronic Kidney Disease N=15                                                  N=12,003 
% of patients treated with ACE inhibitor or angiotensin receptor 
blocker (unless contraindicated) 
4/15 (26.7%) 1,678/9,228 (18.2%) 1.28 (0.35-4.74) 0.6890 
% of patients with a  record of blood pressure  in the previous 15 
months 
2/15 (13.3%) 122/13,414 (0.9%) - - 
% of patients with a blood pressure of 140/85 or less  in the 
previous 15 months 
4/15 (26.7%) 3,801/13,414 (28.3%) 0.98 (0.27-3.56) 0.9770 
Psychosis N=55                                                  N=6,899 
% of patients with a record of comprehensive care plan agreed 
with individual, family or carer 
5/40 (12.5%) 970/5,858 (16.6%) 1.62 (0.51-5.17) 0.4047 
% of patients with a record of review and evidence of 
participation in routine health promotion/prevention advice  in 
the previous 15 months 
7/53 (13.2%) 826/5,966 (13.8%) 2.05 (0.75-5.56) 0.1541 
% of patients on lithium therapy with a record of lithium levels in 
a therapeutic range in the previous 6 months 
7/11 (63.6%) 85/ 987 (8.6%) - - 
% of patients on lithium therapy with a record of serum creatinine 
and TSH   in the previous 15 months 
7/11 (63.6%) 49/1,023 (4.8%) - - 
Atrial Fibrillation N=7                                                    N=9,953 
% of patients treated with anti-coagulant or anti-platelet drug 
therapy 
2/7 (28.6%) 293/9,934 (2.9%) - - 
% of patients from 1.4.07 with diagnosis confirmed by EEG 
specialist  
1/4 (25.0%) 203/1,581 (12.8%) - - 
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Stroke N=13                                                  N=15,008 
% of patients with a record of total cholesterol  in the previous 15 
months 
 1/13 (7.7%) 1,355/15,046 (9.0%) - - 
% of patients with a total cholesterol of 5mmol/l or less in the 
previous 15 months 
2/13 (15.4%) 2,394/15,046 (15.9%) 0.95 (0.17-5.30) 0.9483 
% of patients with a record of blood pressure in the previous 15 
months 
0/13 (0.0%) 637/15,046 (4.2%) - - 
% of patients with a blood pressure reading of 150/90 or less in 
the previous 15 months 
0/13 (0.0%) 1,128/15,046 (7.5%) - - 
% of patients with non-haemorrhagic stroke or history of 
transient ischaemic attacks with record of taking anti-platelet or 
anti-coagulant (unless contraindicated) 
1/13 (7.7%) 383/9,130 (4.2%) 2.18 (0.21-22.55) 0.4789 
% of patients with a record of influenza immunisation in the 
preceeding 1 September – 31 March  
1/13 (7.7%) 3,080/15,046 (20.5%) 0.30 (0.03-3.03) 0.2778 
% of new patients with a stroke with a record of referral for 
further investigation 
3/4 (75.0%) 151/1,021 (14.8%) - - 
Depression N=66                                                  N=54,370 
% on diabetes or coronary heart disease register for whom case 
finding for depression has been undertaken 
22/66 (33.3%) 3,790/54,284 (7.0%) 6.73 (3.79-11.95) <0.0001 
Health Promotion      
% of patients with any of the following: coronary heart disease, 
stroke or TIA, hypertension, diabetes, COPD or asthma, who have 
a record of smoking status in the previous 15 months, except 
never-smokers who need the recording once since diagnosis 
6/190 (3.2%) 842/155,235 (0.5%) 5.50 (2.28-13.27) 0.0002 
% of patients with record of smoker status with any  of: coronary 
heart disease, stroke or TIA, hypertension, diabetes, COPD or 
asthma, who are offered smoking cessation advice or specialist 
referral  
24/53 (45.3%) 510/39,830 (1.3%) 115.56 (55.99-
238.51) 
<0.0001 
